Attached files
| file | filename |
|---|---|
| EX-14 - NOVAVAX INC | v176992_ex14.htm |
| EX-10.14 - NOVAVAX INC | v176992_ex10-14.htm |
| EX-10.45 - NOVAVAX INC | v176992_ex10-45.htm |
| EX-10.15 - NOVAVAX INC | v176992_ex10-15.htm |
| EX-10.11 - NOVAVAX INC | v176992_ex10-11.htm |
| EX-10.19 - NOVAVAX INC | v176992_ex10-19.htm |
| EX-10.13 - NOVAVAX INC | v176992_ex10-13.htm |
| EX-10.37 - NOVAVAX INC | v176992_ex10-37.htm |
| EX-31.2 - NOVAVAX INC | v176992_ex31-2.htm |
| EX-31.1 - NOVAVAX INC | v176992_ex31-1.htm |
| EX-32.2 - NOVAVAX INC | v176992_ex32-2.htm |
| EX-32.1 - NOVAVAX INC | v176992_ex32-1.htm |
| 10-K - NOVAVAX INC | v176992_10k.htm |
Exhibit
23.1
CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We have
issued our report dated March 16, 2010, with respect to the consolidated
financial statements, schedule and internal control over financial reporting
included in the Annual Report of Novavax, Inc. and subsidiary on Form 10-K for
the year ended December 31, 2009. We hereby consent to the incorporation by
reference of said report in the Registration Statements of Novavax, Inc. and
subsidiary on Forms S-3 (No. 333-118210 effective August 13, 2004;
No. 333-118181 effective August 12, 2004; and No. 333-22685
effective March 4, 1997) and on Forms S-8 (No. 333-145298 effective
August 9, 2007; No. 33-80277 effective December 11, 1995;
No. 33-80279 effective December 11, 1995; No. 333-130990 effective
January 12, 2006; No. 333-110401 effective November 12, 2003;
No. 333-97931 effective August 9, 2002; No. 333-46000 effective
September 18, 2000 and No. 333-77611, effective May 3,
1999).
/s/ Grant
Thornton LLP
Baltimore,
Maryland
March 16,
2010